Of course, some retails look at the yahoo for DEPO estimates and they may not realize that numbers are not real. On other hand, the fake income reflected in the estimates may fool some people.
The income was negative and may be negative to flat for this year. 2015 will not be the year for DEPO especially the way DEPO progress like a turtle. I wondering if a mistake wipes out the cash or the company sits on its cash until situation turns against the company. No taking a risk is a big risk.
They could do a $100MM acquisition, but it would probably be non-accretive and preclude their ability to do more, smaller deals. The 9 figure price tags also have large pharma circling the waters and they don't want to get caught up in a protracted bidding war. Sales force is primarily a fixed expense, so adding more products make the smaller acqusitions immediately accretive.